Clinical Trial Update: HTL0039732 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

HTL0039732 is being evaluated in a Phase 1/2 study for multiple advanced solid tumours and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Lung Cancer
• Malignant Mesothelioma
• Pancreatic Cancer

Drugs mentioned

• HTL0039732

Snippet

Sponsor: Cancer Research UK | Conditions: Neoplasms, Prostatic Neoplasms, Castration-Resistant | Phase 1, Phase 2 | Status: RECRUITING